Matthew Wheatley

ORCID: 0000-0002-2979-687X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiation Dose and Imaging
  • Advanced Radiotherapy Techniques
  • Lung Cancer Diagnosis and Treatment
  • Intraocular Surgery and Lenses
  • Glaucoma and retinal disorders
  • Glioma Diagnosis and Treatment
  • Urological Disorders and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Retinal and Optic Conditions
  • Endometrial and Cervical Cancer Treatments
  • Retinal and Macular Surgery
  • Radiomics and Machine Learning in Medical Imaging
  • Virus-based gene therapy research
  • Cytomegalovirus and herpesvirus research
  • Ultrasound and Hyperthermia Applications
  • Advanced MRI Techniques and Applications
  • Retinal Imaging and Analysis
  • Retinal Development and Disorders
  • Retinal Diseases and Treatments
  • Medical Imaging Techniques and Applications
  • Ocular Surface and Contact Lens

Rutgers, The State University of New Jersey
2010-2021

Mercy Medical Center
2016-2021

Johnson University
2021

Mercy General Hospital
2021

Mercy San Juan Medical Center
2020

Dignity Health
2020

Columbia University
2002

Manhattan Eye, Ear and Throat Hospital
2000

Vitreous Retina Macula Consultants of New York
2000

To quantitatively predict the impact of cardiopulmonary dose on overall survival (OS) after radiotherapy for locally advanced non-small cell lung cancer.We used NRG Oncology/RTOG 0617 dataset. The model building procedure was preregistered a public website. Patients were split between training and set-aside validation subset (N = 306/131). 191 candidate variables covered disease, patient, treatment, dose-volume characteristics from multiple substructures (atria, lung, pericardium,...

10.1158/1078-0432.ccr-19-2627 article EN public-domain Clinical Cancer Research 2020-05-12

To investigate visual acuity and fluorescein angiographic outcomes, as well adverse events, associated with treatment of retinal angiomatous proliferation (RAP) micropulsed laser photocoagulation intravitreal triamcinolone acetonide injection.In this retrospective, noncomparative, interventional, consecutive case series, the medical records all patients treated for RAP (yellow or green dye; duration, 0.02-0.05 second; power adjusted to achieve a white burn moderate intensity at level lesion...

10.1097/iae.0b013e3180ed45a6 article EN Retina 2007-11-01

From the Vitreous, Retina, Macula Consultants of New York, LuEsther T. Mertz Retina Research Laboratory, Manhattan Eye, Ear and Throat Hospital, York. The authors have no proprietary interests relevant to this study. Reprint requests: Richard F. Spaide, MD, Suite 203, 519 East 72nd Street, NY 10021.

10.1097/00006982-200001000-00022 article EN Retina 2000-01-01
Coming Soon ...